Investors bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Thursday. $259.32 million flowed into the stock on the tick-up and $178.48 million flowed out of the stock on the tick-down, for a money net flow of $80.84 million into the stock. Of all companies tracked, UnitedHealth Group had the 4th highest net in-flow for the day. UnitedHealth Group traded down ($0.49) for the day and closed at $266.81
Several brokerages have recently weighed in on UNH. BMO Capital Markets increased their price objective on shares of UnitedHealth Group to $310.00 and gave the company an “outperform” rating in a research report on Thursday. Goldman Sachs Group reissued a “buy” rating and issued a $277.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 17th. Piper Jaffray Companies increased their price objective on shares of UnitedHealth Group to $300.00 and gave the company an “overweight” rating in a research report on Wednesday. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a research report on Wednesday, July 18th. Finally, Raymond James increased their price objective on shares of UnitedHealth Group from $304.00 to $310.00 and gave the company a “strong-buy” rating in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, twenty-three have given a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $289.41.
The company has a current ratio of 0.69, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61. The company has a market cap of $256.80 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 1.54 and a beta of 0.73.
In related news, CEO Steven H. Nelson sold 8,142 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the sale, the chief executive officer now directly owns 22,496 shares in the company, valued at approximately $5,961,440. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, August 1st. The stock was sold at an average price of $254.79, for a total transaction of $3,821,850.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 94,568 shares of company stock worth $24,950,027. 0.87% of the stock is owned by corporate insiders.
Institutional investors have recently added to or reduced their stakes in the business. White Lighthouse Investment Management Inc. bought a new position in UnitedHealth Group during the 2nd quarter worth approximately $324,000. Wells Fargo & Company MN raised its holdings in UnitedHealth Group by 0.5% during the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after purchasing an additional 39,480 shares during the last quarter. Wesbanco Bank Inc. raised its holdings in UnitedHealth Group by 195.2% during the 1st quarter. Wesbanco Bank Inc. now owns 76,341 shares of the healthcare conglomerate’s stock worth $16,337,000 after purchasing an additional 50,480 shares during the last quarter. Granite Investment Advisors LLC raised its holdings in UnitedHealth Group by 1.4% during the 2nd quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock worth $8,397,000 after purchasing an additional 476 shares during the last quarter. Finally, M Holdings Securities Inc. increased its stake in shares of UnitedHealth Group by 12.1% in the 2nd quarter. M Holdings Securities Inc. now owns 5,128 shares of the healthcare conglomerate’s stock valued at $1,258,000 after acquiring an additional 553 shares in the last quarter. Hedge funds and other institutional investors own 85.42% of the company’s stock.
UnitedHealth Group Company Profile (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Fundamental Analysis – How It Helps Investors
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.